Genetic Engineering in IVF for Monogenic Disorders
P
Peter Attia MD discusses genetic engineering in a YouTube video.
General HealthMedical
Story of claim
Peter Attia MD suggests using genetic engineering primarily through IVF for treating monogenic disorders, as in utero methods are too challenging. This approach targets diseases with no other treatments.
- Goal: The goal is to provide a viable treatment for monogenic disorders through IVF where no other options exist.
- Proof: Peter Attia claims IVF is the most feasible method for applying genetic engineering to treat monogenic disorders.
- Nuances:
- In utero genetic engineering remains technically challenging.
- IVF is considered the most practical application.
- Impact on Life: This could potentially lead to healthier generations by preventing certain genetic disorders from being passed on.
Investments
- Price: Costs are not specified but IVF and genetic engineering are typically expensive.
- Time: Timeframes for treatment success are not detailed.
- Effort: Requires significant medical intervention and ethical considerations.
Risks
Potential ethical concerns and technical challenges in genetic engineering remain.
Get Started 🚀
- Consult with genetic specialists about the feasibility of IVF for specific disorders.
- Explore available genetic counseling services.
- Stay informed about advances in genetic engineering technologies.
Brogevity AI can make mistakes. Check important info.